Benzinga | Jul 21, 2021 08:10AM EDT

Nektar Therapeutics Posts Study Titled 'BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)' To ClinicalTrials.Gov

https://clinicaltrials.gov/ct2/show/NCT04969861